نتایج جستجو برای: eluting stents outcome assessment

تعداد نتایج: 903119  

Journal: :Cardiovascular revascularization medicine : including molecular interventions 2006
Giuseppe Mezzapelle Roberto Baglini Duccio Baldari

BACKGROUND The intrinsic thrombogeneity of stents was the historic limitation to their usage during the early phases of stenting. The risk of stent thrombosis has been minimized by the widespread use of platelet antiaggregation. Nowadays, the risk of subacute stent thrombosis is around 1%. Thrombotic risk depends on several factors, such as type of stent, complexity of lesion, and clinical pict...

Journal: :Journal of the American College of Cardiology 2007
Uta C Hoppe

1. Iakovow I, Schmidt T, Bonizzoni E, et al. Incidence, predictors and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126–30. 2. Kuchulakanti PK, Chu WW, Torguson R, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus and paclitaxel-eluting stents. Circulation 2006;113; 1108 –13. 3. Alfonso F, Suarez A, ...

Journal: :Jacc-cardiovascular Interventions 2021

The aim of this study was to investigate the safety and efficacy biodegradable-polymer sirolimus-eluting stents (BP-SES) compared with durable-polymer everolimus-eluting (DP-EES) in patients ST-segment elevation myocardial infarction (STEMI). Primary percutaneous coronary intervention (PCI) is an effective treatment for STEMI, long-term outcomes are determined by profile newest generation drug-...

Journal: :journal of cardio-thoracic medicine 0
amir hossein khosh nasab resident of cardiology, faculty of medicine, mashhad university of medical sciences, mashhad, iran mahmoud mohammadzadeh shabestri cardiologist,faculty of medicine, mashhad university of medical sciences, mashhad, iran ali eshraghi cardiologist,faculty of medicine, mashhad university of medical sciences, mashhad, iran majid jalalyazdi cardiologist, faculty of medicine, mashhad university of medical sciences, mashhad, iran

introduction: this study aimed to evaluate the effects of four-time inflation of the stent balloon at nominal pressure on optimal stent expansion in resistant lesions. materials and methods: this interventional study was conducted on 39 patients with coronary artery lesions, in whom zotarolimus-eluting stents (n=20), paclitaxel-eluting stents (n=11) and other stents (n=8) were deployed four tim...

2014
Navin Nikam Toby B Steinberg Daniel H Steinberg

The introduction of intracoronary stents represented a major advance in interventional cardiology. While bare metal stents set the benchmark for improved safety over angioplasty, intimal hyperplasia and subsequent restenosis were important limitations. First-generation drug-eluting stents demonstrated significant improvements in efficacy, but not necessarily safety, and further technologic deve...

Journal: :Revista espanola de cardiologia 2004
Mariano Valdés Chávarri

The efficacy of drug-eluting stents measured as the late loss, percentage neointimal volume, restenosis, target lesion revascularization and major cardiac events is significantly better than that of bare metal stents. The incidence of thrombosis and aneurysms is similar. Although there is a slight increase in late apposition, this is not followed by an increase in cardiac events. Despite the ar...

2016
Bin Wang Gary S. Mintz Bernhard Witzenbichler Cristiano F. Souza D. Christopher Metzger Michael J. Rinaldi Peter L. Duffy Giora Weisz Thomas D. Stuckey Bruce R. Brodie Mitsuaki Matsumura Myong‐Hwa Yamamoto Rupa Parvataneni Ajay J. Kirtane Gregg W. Stone Akiko Maehara

BACKGROUND The impact of acute stent malapposition (ASM) on long-term clinical outcomes in patients undergoing percutaneous coronary intervention is still controversial. We sought to evaluate predictors and long-term clinical outcomes of ASM. METHODS AND RESULTS ADAPT-DES (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents) was a prospective multicenter study of 8663 patients un...

2013
Frank M Sanfilippo Jamie M Rankin Michael ST Hobbs Michael Nguyen Matthew W Knuiman Patricia Berg Eric G Whitford Randall Hendriks Bernard E Hockings Michael Muhlmann Mark Newman Robert Larbalestier Ian Gilfillan Thomas G Briffa

BACKGROUND Increasing rates of percutaneous coronary intervention (PCI) and decreasing rates of coronary artery bypass graft (CABG) surgery followed the introduction of drug eluting stents in Western Australia in 2002. We assessed the impact of these changes on one-year outcomes for the total population of patients undergoing coronary artery revascularisation procedures (CARP) in Western Austra...

Journal: :Journal of the American College of Cardiology 2014
Fernando Alfonso Maria Jose Pérez-Vizcayno Alberto Cárdenas Bruno García Del Blanco Bernhard Seidelberger Andrés Iñiguez Manuel Gómez-Recio Mónica Masotti M Teresa Velázquez Juan Sanchís Arturo García-Touchard Javier Zueco Armando Bethencourt Rafael Melgares Angel Cequier Antonio Dominguez Vicente Mainar José R López-Mínguez José Moreu Vicens Martí Raúl Moreno Pilar Jiménez-Quevedo Nieves Gonzalo Cristina Fernández Carlos Macaya

OBJECTIVES This study sought to compare the efficacy of drug-eluting balloons (DEB) with that of everolimus-eluting stents (EES) in patients with bare-metal stents (BMS) in-stent restenosis (ISR). BACKGROUND Treatment of patients with ISR remains a challenge. METHODS This was a prospective, multicenter, randomized trial comparing DEB with EES in patients with bare-metal stents (BMS) in-sten...

2010
Mehmet Cilingiroglu Steven R Bailey

Drug-eluting stents are considered a breakthrough in the treatment of coronary artery disease owing to their ability to reduce rates of restenosis and the subsequent need for target lesion revascularization. The literature has limited reports of long-term results of drug-eluting stent implantation with respect to vascular integrity and coronary endothelial function. Thus, we review the currentl...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید